Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Sparsentan | Sparsentan (RE-021) is a highly potent dual angiotensin II and endothelin A receptor antagonist with K i s of 0.8 and 9.3 nM, respectively [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: RE-021; DARA-a. CAS No. 254740-64-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-17621. |  |
| Sparsentan | Sparsentan. Uses: For analytical and research use. Group: Impurity standards. CAS No. 254740-64-2. Molecular Formula: C32H40N4O5S. Mole Weight: 592.76. Catalog: APB254740642. |  |
| Sparsentan-D5 | Sparsentan-D5. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1801597-09-0. Molecular Formula: C32H35D5N4O5S. Mole Weight: 597.79. Catalog: APB1801597090. | |
| Sparsentan impurity 1 | Sparsentan impurity 1. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C30H35ClN4O4S. Mole Weight: 583.15. Catalog: APB12091. | |
| Sparsentan impurity 10 | Sparsentan impurity 10. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1026355-73-6. Molecular Formula: C34H44N4O6S. Mole Weight: 636.81. Catalog: APB1026355736. | |
| Sparsentan impurity 11 | Sparsentan impurity 11. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1255948-71-0. Molecular Formula: C10H13BrO2. Mole Weight: 245.12. Catalog: APB1255948710. | |
| Sparsentan impurity 12 | Sparsentan impurity 12. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1255948-72-1. Molecular Formula: C11H15BrO4S. Mole Weight: 323.2. Catalog: APB1255948721. | |
| Sparsentan impurity 13 | Sparsentan impurity 13. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1255948-74-3. Molecular Formula: C23H31BrN2O6. Mole Weight: 511.41. Catalog: APB1255948743. | |
| Sparsentan impurity 2 | Sparsentan impurity 2. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1399412-15-7. Molecular Formula: C32H38N4O6S. Mole Weight: 606.74. Catalog: APB1399412157. | |
| Sparsentan impurity 3 | Sparsentan impurity 3. Uses: For analytical and research use. Group: Impurity standards. CAS No. 254737-96-7. Molecular Formula: C30H34N4O5S. Mole Weight: 562.69. Catalog: APB254737967. | |
| Sparsentan impurity 4 | Sparsentan impurity 4. Uses: For analytical and research use. Group: Impurity standards. CAS No. 347852-72-6. Molecular Formula: C10H10Br2O2. Mole Weight: 322. Catalog: APB347852726. | |
| Sparsentan impurity 5 | Sparsentan impurity 5. Uses: For analytical and research use. Group: Impurity standards. CAS No. 948349-66-4. Molecular Formula: C12H15BrO3. Mole Weight: 287.15. Catalog: APB948349664. | |
| Sparsentan impurity 6 | Sparsentan impurity 6. Uses: For analytical and research use. Group: Impurity standards. CAS No. 415697-58-4. Molecular Formula: C13H17BN2O6S. Mole Weight: 340.16. Catalog: APB415697584. | |
| Sparsentan impurity 7 | Sparsentan impurity 7. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1247868-68-3. Molecular Formula: C25H30N2O7S. Mole Weight: 502.58. Catalog: APB1247868683. | |
| Sparsentan impurity 8 | Sparsentan impurity 8. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1098924-76-5. Molecular Formula: C23H28N2O6S. Mole Weight: 460.55. Catalog: APB1098924765. | |
| Sparsentan impurity 9 | Sparsentan impurity 9. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1026273-26-6. Molecular Formula: C23H27BrN2O5S. Mole Weight: 523.44. Catalog: APB1026273266. | |
| Sparsentan (RE-021) | Sparsentan, also known as RE-021, BMS346567, is a dual antagonist of both angiotensin II and endothelin A receptor antagonist. Synonyms: 2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)benzenesulfonamide; RE-021; RE021; RE 021; PS-433540; PS433540; PS 433540; DARA-a; Sparsentan. Grades: >98%. CAS No. 254740-64-2. Molecular formula: C32H40N4O5S. Mole weight: 592.75. |  |
| RE-0004090 (PS360814) | An impurity of sparsentan. Sparsentan could be the first FDA-approved pharmacologic treatment for focal segmental glomerulosclerosis (FSGS). Synonyms: [1,?1'-Biphenyl]?-2-sulfonamide, 4'-[(2-butyl-4-oxo-1,?3-diazaspiro[4.4]?non-1-en-3-yl)?methyl]?-N-(4,?5-dimethyl-3-isoxazolyl)?-2'-formyl-; 4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2'-formyl[1,1'-biphenyl]-2-sulfonamide. Grades: > 95%. CAS No. 254737-96-7. Molecular formula: C30H34N4O5S. Mole weight: 562.68. | |
| RE-0004091 (PS359607) | An impurity of sparsentan. Sparsentan could be the first FDA-approved pharmacologic treatment for focal segmental glomerulosclerosis (FSGS). Grades: > 95%. Molecular formula: C30H35ClN4O4S. Mole weight: 583.15. | |
| RE-0004095 (PS701685) | An impurity of sparsentan. Sparsentan could be the first FDA-approved pharmacologic treatment for focal segmental glomerulosclerosis (FSGS). Synonyms: [1,?1'-Biphenyl]?-2-sulfonamide, 4'-[(2-butyl-4-oxo-1,?3-diazaspiro[4.4]?non-1-en-3-yl)?methyl]?-N-(4,?5-dimethyl-3-isoxazolyl)?-2'-formyl-N-(methoxymethyl)?-. Grades: > 95%. CAS No. 1399412-15-7. Molecular formula: C32H38N4O6S. Mole weight: 606.73. | |
Our database is helping our users find suppliers everyday.
